Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 20, 2018 16:05 ET | Source: Entera Bio

Entera Bio Reports Second Quarter 2018 Financial Results and Operating Update

Closed Initial Public Offering on July 2, 2018Completed Part 1 of a Phase 2 PK/PD Study in Hypoparathyroidism Patients Mr. Gerald Lieberman was Appointed as Chairman of the Board of Directors ...
August 09, 2018 12:00 ET | Source: Entera Bio

Entera Bio Ltd. Announces Appointment of Mr. Gerald Lieberman as Chairman of the Board of Directors

JERUSALEM, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX and ENTXW), announced today the appointment of Mr. Gerald Lieberman as the chairman of the board of directors, effective as...
August 01, 2018 08:00 ET | Source: Entera Bio

Entera Bio Completes Part 1 of a Phase 2 PK/PD Study in Hypoparathyroidism Patients

A second and final part of the study will evaluate selected dose regimens chosen based on part 1 JERUSALEM, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (Nasdaq: ENTX), announced today that it...
July 02, 2018 16:05 ET | Source: Entera Bio

Entera Bio Ltd. Announces Closing of Initial Public Offering

JERUSALEM, July 02, 2018 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ:ENTX) (NASDAQ:ENTXW), a clinical-stage biopharmaceutical company focused on the development and commercialization of orally...
June 28, 2018 08:53 ET | Source: Entera Bio

Entera Bio Ltd. Announces Pricing of Initial Public Offering

JERUSALEM, June 28, 2018 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ:ENTX) (NASDAQ:ENTXW), a clinical-stage biopharmaceutical company focused on the development and commercialization of orally...